News

Article

Fall Clinical Dermatology 2024 | Conference Preview

Author(s):

Key Takeaways

  • The conference offers insights into dermatologic advancements, including surgical, medical, and cosmetic procedures, with both in-person and virtual attendance options.
  • Expert speakers will present on significant advances in dermatology, including updates on patient management and therapeutic options.
SHOW MORE

This overview highlights our upcoming conference coverage at the Fall Clinical Dermatology Conference in Las Vegas.

Fall Clinical Dermatology 2024 | Conference Preview

The 44th Annual Fall Clinical Dermatology conference begins October 24, 2024. The Fall Clinical Dermatology Conference lasts for 4 days and features a variety of presentations and data on an array of different dermatologic conditions related to surgical, medical, and cosmetic procedures.

The conference itself is being held at the Wynn Las Vegas hotel and casino in Nevada and can also be attended virtually. In addition to its coverage of the latest advances in patient management, Fall Clinical may also allow for an opportunity for attendees to network with experts in the field of dermatology,

The HCPLive editorial team is going to be on-site, covering updates and conducting interviews with presenters at Fall Clinical. The curriculum of this conference provides updates on key topics in the field, and the content has been structured to provide cutting-edge insights and to allow for professional growth opportunities within the dermatologic community.

The 2024 conference is set to provide insights on many of the most significant advances made in the field of dermatology as well as pipeline news and recent data on therapeutic options. The meeting’s line-up features a plethora of expert speakers touching on some of these updates.

Notable Interviews:

Interviews with the HCPLive team on-site are planned for a variety of featured guests, some of which include the following:

  • Neal Bhatia, MD, director of clinical dermatology at Therapeutics Clinical Research and the chief medical editor for Practical Dermatology.
  • Laura Korb Ferris, MD, PhD, professor at the University of Pittsburgh’s Clinical and Translational Science Institute and director of the clinical trials unit at UPMC’s Department of Dermatology.
  • James Del Rosso, DO, FAOCD, research director of JDR Dermatology Research and president of the American Acne and Rosacea Society.
  • Eingun James Song, MD, associate chief medical officer and director of clinical research at Frontier Dermatology.
  • Andrea T. Murina, MD, associate professor of dermatology and the program director at Tulane University School of Medicine in New Orleans.

Notable Sessions

These speakers and others are slated to highlight some of the most notable developments and updates in treatment and management research. In terms of presentations attendees may wish to view, some of the most notable ones include the following:

What’s New in the Medicine Chest - Parts 1 and 2

These 2 presentations will be hosted at the conference by James Del Rosso, DO.

Managing Facial Hyperpigmentation in All Skin Types and Colors

This presentation is scheduled for Thursday, October 24, and will be hosted by Andrew F. Alexis, MD, MPH, professor of clinical dermatology at Weill Cornell Medicine.

What’s New in Biologic Therapy of Psoriasis

This presentation is scheduled for Friday, October 25, and hosted by Mark Lebwohl, MD.

Beyond the Biopsy: Other Methods To Help Us Manage Skin Cancer

This presentation is set to occur on Saturday, October 26, and will be hosted by Neal D. Bhatia, MD, and Laura K. Ferris, MD, PhD.

Follow our latest conference coverage here to stay up-to-date about onsite interviews with dermatologists, the contents of these presentations, and the latest developments in the field that are covered at Fall Clinical.

Related Videos
A. Sidney Barritt, MD | Credit: UNC School of Medicine
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
Marianna Fontana, MD, PhD: Declines in Kidney Function Frequent in ATTR-CM  | Image Credit: Radcliffe Cardiology
Wei Zhang, MD, PhD: Naltrexone’s GI, Liver Safety for Alcohol Use Disorder Treatment
Jeffrey Teckman, MD | Credit: AASLD
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Christian T. Ruff, MD, MPH: Abelacimab Cuts Bleeding Risk Versus Rivaroxaban| Image Credit: Brigham & Women's Hospital
Barry A. Borlaug, MD: Impact of Tirzepatide on Cardiorenal End-Organ Damage | Image Credit: Mayo Clinicn HFpEF
© 2024 MJH Life Sciences

All rights reserved.